BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12366501)

  • 1. Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units.
    Walther SM; Erlandsson M; Burman LG; Cars O; Gill H; Hoffman M; Isaksson B; Kahlmeter G; Lindgren S; Nilsson L; Olsson-Liljequist B; Hanberger H;
    Acta Anaesthesiol Scand; 2002 Oct; 46(9):1075-81. PubMed ID: 12366501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High antibiotic susceptibility among bacterial pathogens in Swedish ICUs. Report from a nation-wide surveillance program using TA90 as a novel index of susceptibility.
    Hanberger H; Erlandsson M; Burman LG; Cars O; Gill H; Lindgren S; Nilsson LE; Olsson-Liljequist B; Walther S;
    Scand J Infect Dis; 2004; 36(1):24-30. PubMed ID: 15000555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of antibiotic resistance in ICUs in southeastern Sweden. ICU Study Group of the South East of Sweden.
    Erlandsson CM; Hanberger H; Eliasson I; Hoffmann M; Isaksson B; Lindgren S; Nilsson LE; Sörén L; Walther SM
    Acta Anaesthesiol Scand; 1999 Sep; 43(8):815-20. PubMed ID: 10492409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription of antibiotic agents in Swedish intensive care units is empiric and precise.
    Erlandsson M; Burman LG; Cars O; Gill H; Nilsson LE; Walther SM; Hanberger H;
    Scand J Infect Dis; 2007; 39(1):63-9. PubMed ID: 17366015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nationwide evaluation of antibiotics consumption in Swedish intensive care units.
    Sjövall F; Edström M; Walther S; Hanberger H
    Infect Dis (Lond); 2022 Oct; 54(10):713-721. PubMed ID: 35638173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quality assurance in intensive care medicine. SARI-surveillance on antibiotic use and bacterial resistance in intensive care units].
    Meyer E; Schroeren-Boersch B; Schwab F; Jonas D; Rüden H; Gastmeier P; Daschner FD
    Anaesthesist; 2004 May; 53(5):427-33. PubMed ID: 15004690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
    Nikodemski T
    Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004.
    Meyer E; Schwab F; Gastmeier P; Rueden H; Daschner FD
    Infection; 2006 Dec; 34(6):303-9. PubMed ID: 17180583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High antibiotic consumption in Danish intensive care units?
    Petersen IS; Hesselbjerg L; Jørgensen L; Renstrup J; Barnung S; Schierbeck J; Jepsen OB
    APMIS; 1999 Nov; 107(11):989-96. PubMed ID: 10598870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic usage and resistance - trends in Estonian University Hospitals.
    Naaber P; Kõljalg S; Maimets M
    Int J Antimicrob Agents; 2000 Nov; 16(3):309-15. PubMed ID: 11091054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategic alliance between the infectious diseases specialist and intensive care unit physician for change in antibiotic use.
    Curcio D; Belloni R
    J Chemother; 2005 Feb; 17(1):74-6. PubMed ID: 15828447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels.
    Hanberger H; Antonelli M; Holmbom M; Lipman J; Pickkers P; Leone M; Rello J; Sakr Y; Walther SM; Vanhems P; Vincent JL;
    BMC Infect Dis; 2014 Sep; 14():513. PubMed ID: 25245620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations and determinants of antibiotic consumption in Hungarian adult intensive care units.
    Benko R; Matuz M; Peto Z; Bogár L; Viola R; Doró P; Soós G; Hajdú E
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):104-9. PubMed ID: 21796720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic stewardship in Germany: a cross-sectional questionnaire survey of 355 intensive care units.
    Maechler F; Schwab F; Geffers C; Meyer E; Leistner R; Gastmeier P
    Infection; 2014 Feb; 42(1):119-25. PubMed ID: 24135909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diversity in antibiotic use in intensive care units in Germany].
    Meyer E; Schwab F; Schroeren-Boersch B; Rüden H; Gastmeier P
    Dtsch Med Wochenschr; 2008 Feb; 133(6):235-40. PubMed ID: 18236348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic prescription in intensive care units in Latin America.
    Curcio DJ;
    Rev Argent Microbiol; 2011; 43(3):203-11. PubMed ID: 22430995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increased antibiotic resistance of intestinal bacteria].
    Hanberger H; Nilsson LE
    Lakartidningen; 1996 Jan; 93(3):148-51, 154. PubMed ID: 8569329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
    Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S
    Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.